Home / Resources / Articles / Propensity for Obesity, Diabetes, May Occur in Utero

Propensity for Obesity, Diabetes, May Occur in Utero

Apr 26, 2005
1,290 views
 

The adage “You are what you eat” should be rephrased to include “and so are your children,” based on metabolic research pioneered by researchers at the University at Buffalo. Previous studies by the UB scientists showed that rat pups raised artificially on a high-carbohydrate milk formula identical in calories to mother’s milk developed changes in pancreatic islets, resulting in overproduction of insulin and obesity in adulthood. The progeny of these high-carbohydrate (HC) mothers raised naturally also develop the same maladjustments, they found.

The researchers now have shown that this metabolic "malprogramming" is permanent and occurs in utero, resulting in the next generation born to HC mothers carrying the HC phenotype. Rat fetuses had increased plasma insulin levels, increased mRNA levels of preproinsulin, a precursor of insulin, and increased insulin in the pancreas, without an increase in body weight, plasma glucose level or a change in islet structure.

 

They also found changes in the hypothalamus, the brain’s center of appetite regulation, that result in appetite stimulation. While these studies were done with rats, Mulchand Patel, Ph.D, UB distinguished professor of biochemistry and first author on the study, speculated that there is good reason to think the mechanism could be similar in humans.

"Obesity can be perpetuated via the maternal intrauterine environment," said Patel, who reported the findings at the 2005 Experimental Biology meeting held in San Diego in early April.

"Our earlier studies looked at progeny in the post-weaning period, so we didn’t know how early this malprogramming occurred. Now we know it occurs in utero. We predicted that this could be the case, and our present findings support this prediction."

Plasma levels of rat pups (2-HC) born to HC mothers returned to normal during the suckling period, results showed, but islets from 12-day-old suckling 2-HC rats showed a capacity for insulin oversecretion when maintained in culture medium containing high glucose levels. By the 28th day, approximately 4 days after weaning to rat chow, 2-HC rats once again had high insulin levels and showed a higher capacity for insulin secretion to a glucose stimulus. Even on rat chow, body weight began to increase around day 55, and 2-HC rats were obese by post-natal day 100.

Patel speculated that in humans, it’s possible such malprogramming could be interrupted if an obese/insulin resistant mother brought body weight and plasma insulin levels back to normal before becoming pregnant.

The research at the University of Buffalo, was supported by grants from the National Institutes of Health. Findings reported at the 2005 Experimental Biology meeting held in San Diego in early April, 2005
Cell Metabolism, April 2005.

===============================

FACT:

Home Dialysis Device Approved by US FDA: Fresenius Medical Care has received U.S. regulatory clearance for its Liberty Cycler device intended for use at home by kidney disease patients.The U.S. Food and Drug Administration’s 510 (k) clearance means the company can now market the Liberty Cycler within the United States, FMC said in a statement. The Liberty Cycler is used in automated peritoneal dialysis, the fastest-growing home therapy for the treatment of end-stage renal disease, the company said. Liberty Cycle controls the level of dialysis fluids in the body and the temperature of the blood, a spokesman said.

===============================
Advertisement
The world’s smallest meter. The world’s smallest sample size. And the most sites from which to test. FreeStyle Flash provides exactly what you have come to expect when you think of FreeStyle – reliability and virtually painless testing with unsurpassed accuracy. Click Here:
https://www.diabetesincontrol.com/ads/therasense/dest.shtml